PYRUKIND [mitapivat]
搜索文档
Agios: 'Sell' On Tebapivat Setback LR-MDS And Competitive PK Activator Drug Class (AGIO)
Seeking Alpha· 2026-05-30 04:11
Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his ...